drugset / Trial / NCT00228319
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
Phase 1/2
Completed
27 enrolled
Jeanne Drisko, MD, CNS, FACN
Cancer Treatment Research Foundation · collabUniversity of Kansas Medical Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer.
Timeline
- Start
- 2002-10
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Ascorbate | Small molecule | 0.5 g | Intravenous |
| Background | Carboplatin | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |